Clinical Drug Experience Knowledgebase

imatinib (gleevec) (7 trials)

nilotinib (tasigna) (5 trials)

aldesleukin (proleukin) (1 trial)

allogeneic hematopoietic stem cells (Hemacord) (2 trials)

arsenic trioxide (trisenox) (2 trials)

autologous bone marrow (2 trials)

azacitidine (vidaza) (3 trials)

bleomycin (blenoxane) (1 trial)

blinatumomab (blincyto) (3 trials)

bortezomib (velcade) (3 trials)

busulfan (myleran) (2 trials)

carmustine (bicnu) (1 trial)

cyclophosphamide (cytoxan) (8 trials)

cytarabine (cytosar-u) (11 trials)

dacarbazine (dtic-dome) (1 trial)

daunorubicin (cerubidine) (8 trials)

decitabine (dacogen) (2 trials)

deferasirox (exjade) (1 trial)

doxorubicin (Doxil) (2 trials)

etoposide (vepesid) (8 trials)

fludeoxyglucose f-18 (1 trial)

gemtuzumab ozogamicin (mylotarg) (3 trials)

glasdegib (Daurismo) (1 trial)

ibrutinib (imbruvica) (4 trials)

idarubicin (idamycin) (10 trials)

lamasine (1 trial)

lenalidomide (revlimid) (4 trials)

melphalan (alkeran) (1 trial)

mercaptopurine (purinethol) (6 trials)

midostaurin (rydapt) (1 trial)

mitoxantrone (novantrone) (6 trials)

naltrexone (revia) (6 trials)

obinutuzumab (gazyva) (2 trials)

peripheral blood hematopoietic cell (3 trials)

ponatinib (iclusig) (5 trials)

prednisone (meticorten) (5 trials)

procarbazine (matulane) (1 trial)

sargramostim (leukine) (3 trials)

tioguanine (Lanvis) (2 trials)

tretinoin (Retin-A) (6 trials)

urea (5 trials)

venetoclax (venclexta) (6 trials)

vinblastine (velban) (1 trial)

vincristine (oncovin) (5 trials)

alemtuzumab (campath) (1 trial)

allogeneic stem cells (1 trial)

asparaginase (elspar) (4 trials)

autologous hematopoietic cell (1 trial)

bcr-abl p210-b3a2 breakpoint-derived multipeptide vaccine (1 trial)

bendamustine (treanda) (2 trials)

bosutinib (bosulif) (1 trial)

chlorambucil (Leukeran) (1 trial)

clofarabine (clolar) (3 trials)

dasatinib (sprycel) (2 trials)

eltrombopag (promacta) (3 trials)

fludarabine (fludara) (3 trials)

inotuzumab ozogamicin (besponsa) (1 trial)

interferon alpha-2b (Intron-A) (1 trial)

methylprednisolone (medrol) (2 trials)

ofatumumab (arzerra) (3 trials)

rituximab (rituxan) (4 trials)

tagraxofusp-erzs (elzonris) (1 trial)

temsirolimus (torisel) (1 trial)

tenofovir alafenamide (genvoya) (1 trial)

valproic acid (depakene) (1 trial)

everolimus (zortress) (1 trial)

adrenomedullin (22-52) (1 trial)

ciprofloxacin (cipro) (1 trial)

cotrimoxazole (1 trial)

COVID-19 convalescent plasma (1 trial)

fluconazole (diflucan) (1 trial)

ifosfamide (ifex) (1 trial)

itraconazole (sporanox) (1 trial)

levofloxacin (levaquin) (1 trial)

posaconazole (noxafil) (1 trial)

romiplostim (nplate) (1 trial)